Expression of HLA-DR in intrahepatic cholangiocarcinoma
โ Scribed by Akihito Torii; Akio Harada; Akimasa Nakao; Toshiaki Nonami; Afsuo Nakayama; Masafumi Ito; Hiroshi Takagi
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 693 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The outcome of patients with hepatocellular carcinoma (HCC) remains poor because of the high frequency of intrahepatic recurrence (IHR), particularly early IHR within 1 year of hepatectomy. To search for genes involved in early IHR, we performed DNA microarray analysis in a training set
Intrahepatic cholangiocarcinoma is a neoplasm arising in the liver, and its incidence is increasing in Japan as well as in Western countries. Prognosis of patients with this type of tumor remains unsatisfactory because no effective chemotherapeutic drugs are available, we have no sensitive tumor mar
Background and Objectives: This study was designed to identify a difference in immunostaining that might help to distinguish between primary and metastatic liver neoplasms. Methods: We examined immunohistochemical expression of cytokeratins (CKs) 7, 8, 19, and 20 in 12 intrahepatic cholangiocarcinom